Your browser doesn't support javascript.
loading
Incobotulinum Toxin-A in Professional Musicians with Focal Task-Specific Dystonia: A Double Blind, Placebo Controlled, Cross-Over Study.
Frucht, Steven J; George, Mary Catherine; Pantelyat, Alexander; Altenmueller, Eckart; Nmashie, Alexandra; Jiao, Jocelyn M; Chen, Michael; Feng, David; Shin, Susan; Kaku, Michelle C; Simpson, David.
Afiliação
  • Frucht SJ; New York University Grossman School of Medicine, US.
  • George MC; Icahn School of Medicine at Mount Sinai, US.
  • Pantelyat A; Johns Hopkins School of Medicine, US.
  • Altenmueller E; Institute of Music Physiology and Musicians' Medicine of the University of Music, Drama and Media, Hannover, DE.
  • Nmashie A; Department of Pediatrics, New York Medical College, US.
  • Jiao JM; Stanford University School of Medicine, US.
  • Chen M; Icahn School of Medicine at Mount Sinai, US.
  • Feng D; Icahn School of Medicine at Mount Sinai, US.
  • Shin S; Icahn School of Medicine at Mount Sinai, US.
  • Kaku MC; Icahn School of Medicine at Mount Sinai, US.
  • Simpson D; Icahn School of Medicine at Mount Sinai, US.
Article em En | MEDLINE | ID: mdl-38948014
ABSTRACT

Background:

Musician's focal task-specific dystonia is a complex disorder of fine motor control, with incomplete understanding of its etiology. There have been relatively few trials of botulinum toxin in upper limb task-specific dystonia, and prior studies have yielded variable results, leading to skepticism regarding the utility of this approach in elite performers.

Methods:

We conducted a double-blind, placebo-controlled, randomized, cross-over study of incobotulinum toxin-A in 21 professional musicians with focal upper extremity task-specific dystonia affecting performance on their instrument, using a novel paradigm of initial injections followed by booster injections at two- and four-week intervals. The primary outcome measure was the change in blinded dystonia rating of the active arm by two expert raters using a Clinical Global Impression numeric scale at week 8 compared to enrollment.

Findings:

19 men and 2 women with musicians' dystonia were enrolled over a six-year period. Nineteen patients completed the study. Analysis of the primary outcome measure in comparison to baseline revealed a change in dystonia severity of P = 0.04 and an improvement in overall musical performance of P = 0.027. No clinically significant weakness was observed, and neutralizing antibodies to toxin were not found.

Interpretation:

Despite its small sample size, our study demonstrated a statistically significant benefit of incobotulinum toxin-A injections as a treatment for musicians' task-specific dystonia. Tailoring the use of toxin with booster injections allowed refinement of dosing strategy and outcomes, with benefits that were meaningful to patients clearly visible on videotaped evaluations. In addition to its application to musicians' dystonia, this approach may have relevance to optimize application of botulinum toxin in other forms of focal dystonia such as blepharospasm, cervical dystonia, writer's cramp, and spasmodic dysphonia.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudos Cross-Over / Toxinas Botulínicas Tipo A / Distúrbios Distônicos / Música / Fármacos Neuromusculares Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Tremor Other Hyperkinet Mov (N Y) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudos Cross-Over / Toxinas Botulínicas Tipo A / Distúrbios Distônicos / Música / Fármacos Neuromusculares Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Tremor Other Hyperkinet Mov (N Y) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos